Changeflow GovPing Pharma & Drug Safety Functional Nucleic Acid Molecule and Method - U...
Routine Notice Added Final

Functional Nucleic Acid Molecule and Method - University of Edinburgh

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 25th, 2026
Detected April 2nd, 2026
Email

Summary

The European Patent Office published patent application EP4284935A1 for the University of Edinburgh covering functional nucleic acid molecules and methods. Inventors include Steven Pollard, Ute Koeber, and Mantas Matjusaitis. The patent is classified under IPC C12N (biotechnology) and covers 38 designated contracting states.

What changed

The EPO published patent application EP4284935A1 for a functional nucleic acid molecule and associated methods, filed by the University Court of the University of Edinburgh. The application covers innovations in nucleic acid technology with inventors Steven Pollard, Ute Koeber, and Mantas Matjusaitis. Designated states include all major European Patent Convention member states.

For companies in biotechnology and pharmaceutical research, this patent publication establishes priority rights and provides notice of protected intellectual property. Organizations developing similar functional nucleic acid technologies should review freedom-to-operate implications and consider potential licensing discussions with the University of Edinburgh.

Source document (simplified)

← EPO Patent Bulletin

FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD

Publication EP4284935A1 Kind: A1 Mar 25, 2026

Applicants

The University Court Of
The University of Edinburgh

Inventors

POLLARD, Steven, KOEBER, Ute, MATJUSAITIS, Mantas

IPC Classifications

C12N 15/85 20060101AFI20220805BHEP C12N 15/861 20060101ALI20220805BHEP C12N 15/10 20060101ALI20220805BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4284935A1
Docket
EP4284935

Who this affects

Applies to
Educational institutions Healthcare providers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Research and Development Patent Filing
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.